Elevated blood viscosity is associated with cerebral small vessel disease in patients with acute ischemic stroke by unknown
RESEARCH ARTICLE Open Access
Elevated blood viscosity is associated with
cerebral small vessel disease in patients
with acute ischemic stroke
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Abstract
Background: Increased level of blood viscosity, which is one of the major factors that determine blood rheology,
has been reported as a risk factor or predictor for cerebrovascular events. We investigated how blood viscosity is
associated with acute stroke and chronic radiological manifestations of cerebral small vessel disease, and how
blood viscosity changes after stroke.
Methods: We prospectively enrolled consecutive patients with acute ischemic stroke. Whole blood viscosities at a
low or high shear rate were measured using a scanning capillary tube viscometer, and were referred to as diastolic
blood viscosity (DBV) and systolic blood viscosity (SBV), respectively. Correlations between blood viscosity and acute
stroke etiology or chronic radiological manifestations of cerebral small vessel disease were investigated. The
temporal profiles of blood viscosity at the onset of stroke and follow-up at 1 and 5 weeks were investigated.
Results: Of the 127 patients admitted with acute ischemic stroke, 63 patients were included in the final analyses.
DBV at the onset of stroke was significantly higher in small artery occlusion (SAO) stroke than in other stroke
subtypes (p = 0.037). DBV showed a significant positive correlation with the number of chronic lacunes (r = 0.274, p
= 0.030). The temporal profiles of DBV in SAO stroke showed a transient decrease due to the hydration therapy
after 1 week and recurrent elevation at 5 week follow-up (p = 0.009).
Conclusions: Our study suggests that elevated DBV may play a role in the development of acute and chronic
manifestations of cerebral small vessel disease. The recurring elevation of DBV in SAO stroke indicates that sufficient
hydration and additional therapeutic interventions targeting blood viscosity may be needed in patients with SAO
stroke.
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Background
Increased fibrinogen level, whole blood viscosity, and
plasma viscosity, which are major factors that determine
blood rheology, have been reported as risk factors or
predictors for various cardio- or cerebrovascular events
[1–11]. Whole blood viscosity can be determined
through the complex interactions of blood constituents,
including red blood cells, white blood cells, platelets,
fibrinogen, and other plasma proteins [12, 13]. Whole
blood viscosity measured at a high shear rate of 300 s−1
or more is referred to as systolic blood viscosity (SBV)
[14, 15]. Blood viscosity at a high shear rate represents
the frictional characteristics of fast blood flow, defined
as having a velocity of over 30 cm/s in a vessel with a
large diameter [13]. In the high blood flow state, the in-
ertia force representing the kinetic energy is much larger
than the viscous force that arises from the blood viscos-
ity [15]. Therefore, blood flow is predominantly deter-
mined by the inertia force rather than the viscous force
[15]. Meanwhile, the whole blood viscosity measured at
a low shear rate of 5 s−1 or less is referred to as diastolic
blood viscosity (DBV) [14, 15]. In the low blood flow
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state, in which the blood flows through a vessel with a
smaller diameter or through the distal part of an oc-
cluded vascular segment, blood viscosity becomes a
critical factor for determining the tissue perfusion status
[13]. Therefore, DBV may be attributed more to the
pathophysiology of small vessel disease than SBV. In the
case of coronary microvascular dysfunction without
definite occlusion of the main coronary artery, i.e.
microvascular angina, increased blood viscosity may play
a key role in the deterioration of tissue perfusion at a
microvascular level [16]. A comparable microvascular
dysfunction in the brain may be chronic cerebral ische-
mia due to cerebral small vessel disease [17, 18]. Radio-
logical manifestations, such as white matter hyperintensities,
lacunes, and microbleeds, are known consequences of
impaired microvascular perfusion in the brain and chronic
radiological markers for cerebral small vessel disease
[19, 20].
The role of blood viscosity has been reported in the
stroke population [1–7]. Previous studies, which in-
cluded stroke subtype in the scope of their studies, have
suggested that the blood viscosity measured in small ar-
tery occlusion (SAO) stroke was higher than in other
stroke subtypes, such as large artery atherosclerosis
(LAA) and/or cardioembolism (CE) [2–4]. Based on
these previous studies, we hypothesized that blood vis-
cosity may be closely associated with acute or chronic
manifestations of cerebral small vessel disease. We first
questioned how blood viscosity is related to different eti-
ologies leading to acute stroke. Second, we asked how
blood viscosity is associated with the chronic radio-
logical manifestations of cerebral small vessel disease.
Third, we asked if there is an abnormality in blood vis-
cosity in relation to acute stroke, how it changes after
acute stroke. For the first two questions, we investigated
which stroke subtype at the onset of index stroke and
which chronic radiological manifestations, including
white matter hyperintensities, lacunes, and microbleeds,
are correlated with blood viscosity in patients with acute
ischemic stroke. For the last question, the temporal pro-
files of blood viscosity at both stroke onset and follow-
up were investigated.
Methods
Patients and blood sampling
We prospectively enrolled consecutive acute ischemic
stroke patients who had been admitted within 3 days of
the onset of stroke, from July 2013 to February 2014.
Acute ischemic stroke was confirmed by diffusion-
weighted magnetic resonance imaging (MRI) in all
patients. To minimize the diluting effect on blood
viscosity by hydration therapy, the blood samples used
to measure the baseline blood viscosity levels were
obtained during the initial blood sampling procedure in
the emergency room prior to any medical intervention
including hydration therapy. Follow-up measurements of
blood viscosity were performed twice, at 1 week and
5 weeks after the baseline measurement. To minimize the
transient diluting effect by oral hydration, the samples for
the follow-up measurement were obtained under fasting
state. Patients were instructed not to eat or drink any-
thing, including water, after taking their evening pills until
blood sampling was performed early the next morning.
Blood samples from patients diagnosed with stroke mimic
during the same study period were used with permission,
for comparison with those from patients with acute ische-
mic stroke. This study was approved by the institutional
review board of the Konkuk University Hospital. Written
informed consent was obtained from each patient.
Clinical evaluation
The vascular risk factors and laboratory findings affect-
ing blood viscosity including hemoglobin, hematocrit,
white blood cells, platelets, blood protein, fibrinogen, D-
dimer, BUN/Cr (blood urea nitrogen-to-creatinine) ratio,
and lipid profiles were investigated. The patients were
considered to have hypertension if they were on medica-
tion for hypertension or had a blood pressure of ≥140/
90 mmHg on repeated measurement. Similarly, the pa-
tients were considered to have diabetes mellitus if they
were on medication for diabetes or had a fasting blood
sugar ≥126 mg/dl; and to have hyperlipidemia if they
were on lipid-lowering medications or had an overnight
fasting cholesterol level ≥220 mg/dl or low-density lipo-
protein cholesterol level ≥140 mg/dl. Smoking was de-
fined by the current smoking status. The stroke subtype
was classified according to the modified Trial of Org
10172 in Acute Stroke Treatment classification [21].
Blood viscosity measurement
A scanning capillary tube viscometer (BVD-PR01, Bio-
Visco Inc., Korea) was used to measure whole blood
viscosity [15]. The scanning capillary tube viscometer
simultaneously measures the SBV and DBV, which
correspond to the whole blood viscosities at high and
low shear rates, respectively [15]. Samples containing
3 mL whole blood were collected in a vacutainer
containing ethylenediaminetetraacetic acid (EDTA) anti-
coagulant and stored in a refrigerator at 4 °C until meas-
urement. All the measurements were performed within
24 h of the collection. The whole blood viscosity was
measured over a wide range of shear rates, ranging from
1 to 1000 s−1. In the low shear rate range of 5 s−1 or less,
a whole blood viscosity level of 1 s−1 was selected as the
DBV for our study. In the high shear rate range of 300 s−1
or more, a whole blood viscosity level of 300 s−1 was
selected as the SBV for our study.
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Radiological evaluation
T1-weighted, T2-weighted, fluid attenuation inversion
recovery (FLAIR), and T2* gradient-echo images were
obtained using a 3 T MR system (Signa HDx; GE Med-
ical Systems, Milwaukee, WI, USA). The T1- and T2-
weighted images were obtained during the same imaging
session at the same orientation and slice position:
matrix, 128; field of view, 280 × 280 mm; section thick-
ness, 5 mm; intersection space, 2 mm. The radiological
manifestations associated with small vessel disease in the
brain, such as white matter hyperintensities, lacunes,
and microbleeds were subsequently defined. The severity
of white matter hyperintensities on FLAIR images were
assessed by a scale of periventricular hyperintensity
(PVH) and deep white matter hyperintensity (DWMH)
according to the Fazekas scale [22]. Lacunes were distin-
guished from white matter ischemic changes as small
distinct lesions (<15 mm in diameter) with a low signal
on T1-weighted images, a high signal on T2-weighted
images, and perilesional gliotic changes on FLAIR im-
ages [23]. Lacunes usually had a hyperintense rim
around the cavity on FLAIR images, unlike Virchow
Robin spaces or white matter ischemic changes. Acute
lacunar infarctions that presented as an index stroke
when enrolling patients, were not included in the
analysis. Only previous chronic lacunes were included, re-
gardless of whether they were symptomatic or asymptom-
atic. A microbleed was defined as a small, homogenous,
round signal loss lesion (<10 mm in diameter) on
T2* gradient-echo images [23].
Statistical analysis
The differences in vascular risk factors or laboratory
findings were assessed using a chi square test for dichot-
omized variables, and either an independent t test,
Mann-Whitney U test, or analysis of variance (ANOVA)
with a Tukey’s post-hoc test for continuous variables,
where appropriate. The association between SAO stroke
and the laboratory variables was assessed using a calcu-
lation of crude or adjusted odds ratios with 95% confi-
dence intervals through uni- or multivariate logistic
models. The associations among the laboratory findings,
including DBV, SBV, hematocrit, and fibrinogen levels
were analyzed using a Pearson correlation. The associa-
tions between laboratory and radiological findings were
also analyzed using a Pearson correlation. Differences
were considered statistically significant at p values of <




Of the 127 consecutive patients with acute ischemic
stroke admitted during the study period from July 2013
to February 2014, samples for blood viscosity measure-
ment were obtained from 70 patients (Fig. 1). In order
to homogenize the study population, 16 patients with a
stroke onset of more than 3 days, 4 patients whose
stroke was not confirmed by diffusion-weighted MRI, 6
patients with stroke of other determined etiology, and 7
patients with severe medical or neurological status were
excluded. Of the 94 patients eligible for the study, 24 pa-
tients refused to provide written informed consent. Seven
samples were discarded due to either technical errors or
poor quality. Thus, data from 63 patients were analyzed in
our study. Sixteen patients were included in the stroke
mimic group, which was comprised of 7 patients with
non-specific dizziness, 5 patients with transient weakness
without a vascular cause, 3 patients with vestibular neuro-
nitis, and 1 patient with hypochondriasis. Patients with
Fig. 1 Patient enrollment flow chart
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suspected transient ischemic attack (TIA) were not
included in the stroke mimic group because TIA can be
also influenced by blood viscosity.
Demographic and clinical characteristics of patients
The clinical demographics, radiological findings, and
laboratory findings of patients are presented in
Table 1. The most frequent stroke subtype was SAO
(n = 25, 39.7%) followed by LAA (n = 23, 36.5%), CE
(n = 12, 19.0%), and cryptogenic stroke (Cryp; n = 3,
4.8%). The prevalence of vascular risk factors, except
for atrial fibrillation, were not different among the
stroke subtypes (Table 1).
Blood viscosity, hematocrit, and blood fibrinogen level
The DBV and SBV were significantly correlated with
each other (r = 0.456, p < 0.001). The DBV was signifi-
cantly correlated with hematocrit (r = 0.421, p = 0.001;
Fig. 2a) and the SBV with blood fibrinogen level (r =
0.340, p = 0.01; Fig. 2d).
Blood viscosity and stroke subtypes
The baseline DBV was 274.7 ± 70.9 mP in SAO, followed
by 258.9 ± 46.5 mP in Cryp, 252.0 ± 57.5 mP in CE, and
214.5 ± 75.9 mP in LAA stroke subtypes. The baseline
DBV in SAO was significantly higher than that in other
stroke subtypes (p = 0.037). In addition, the post-hoc test
revealed that the baseline DBV in SAO was significantly
Table 1 Clinical demographics, radiological findings, and laboratory findings for the 63 patients included in the study
Total (n = 63)
SAO
(n = 25, 39.7%)
LAA
(n = 23, 36.5%)
CE
(n = 12, 19.0%)
Cryp
(n = 3, 4.8%)
P value
Blood viscosity (mean ± sd)
Diastolic blood viscosity, mP 274.7 ± 70.9 214.5 ± 75.9 252.0 ± 57.5 258.9 ± 46.5 0.037*
Systolic blood viscosity, mP 45.2 ± 16.0 38.1 ± 12.4 40.0 ± 4.9 39.0 ± 4.7 0.273
Clinical findings
Age, years (mean ± sd) 62.7 ± 12.9 67.0 ± 15.5 71.2 ± 11.6 63.3 ± 7.5 0.335
Male, n (%) 19 (76) 13 (57) 7 (58) 2 (67) 0.513
Hypertension, n (%) 16 (64) 16 (70) 5 (42) 3 (100) 0.207
Diabetes, n (%) 6 (24) 7 (30) 3 (25) 0 (0) 0.716
Hyperlipidemia, n (%) 6 (24) 3 (13) 1 (8) 0 (0) 0.484
Atrial fibrillation, n (%) 0 (0) 0 (0) 9 (75) 0 (0) <0.001
Smoking, n (%) 14 (56) 8 (35) 2 (17) 0 (0) 0.053
Radiological findings, median (IQR)
PVH, Fazekas scale 1 (1–2) 1 (1–2) 1 (1–3) 2 (0–2) 0.872
DWMH, Fazekas scale 1 (0–1.5) 1 (0–2) 1 (0–2.75) 1 (0–1) 0.834
Number of chronic lacunes 1 (0–3) 0 (0–2) 1 (0–2.75) 1 (0–2) 0.255
Number of microbleeds 0 (0–2.5) 0 (0–1) 1 (0–2) 0 (0–2) 0.869
Laboratory findings (mean ± sd)
Hemoglobin, g/dL 14.9 ± 1.8 13.9 ± 1.9 13.6 ± 1.7 13.7 ± 1.9 0.129
Hematocrit, % 43.4 ± 5.2 40.9 ± 5.0 39.8 ± 4.4 40.0 ± 5.0 0.135
White blood cells, 103/μL 7.2 ± 2.0 7.6 ± 2.9 9.5 ± 3.6 6.8 ± 2.6 0.110
Platelets, 103/μL 238 ± 56 227 ± 48 233 ± 80 199 ± 40 0.700
Total protein, gm/dL 7.1 ± 0.5 7.0 ± 0.4 7.2 ± 0.5 7.2 ± 0.1 0.429
Fibrinogen, mg/dL 323 ± 78 335 ± 71 357 ± 70 215 ± 44 0.099
D-dimer, μg/dL 0.44 ± 0.32 0.75 ± 0.92 1.51 ± 1.93 0.28 ± 0.10 0.038**
BUN/Cr ratio 19.0 ± 4.6 23.1 ± 8.2 21.1 ± 5.3 17.3 ± 5.1 0.115
Total cholesterol, mg/dL 176 ± 36 177 ± 28 155 ± 56 140 ± 32 0.192
Low-density lipoprotein, mg/dL 109 ± 32 108 ± 22 94 ± 50 80 ± 30 0.319
Triglycerides, mg/dL 127 ± 61 116 ± 80 70 ± 60 60 ± 35 0.078
Abbreviations: SAO small artery occlusion, LAA large artery atherosclerosis, CE cardioembolism, Cryp cryptogenic stroke, sd standard deviation, IQR interquartile
range, PVH periventricular hyperintensity, DWMH deep white matter hyperintensity, BUN/Cr blood urea nitrogen-to-creatinine
*, p = 0.021, SAO vs. LAA in the post-hoc test; **, p = 0.027, SAO vs. CE in the post-hoc test
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higher compared to that of LAA (p = 0.021; Table 1 and
Fig. 3a). Among laboratory variables which were signifi-
cantly associated with SAO stroke in the univariate analysis,
such as DBV, hemoglobin, and hematocrit, only DBV was
still significant in the multivariate analysis adjusted for mul-
tiple vascular risk factors, including age, sex, hypertension,
diabetes, hyperlipidemia, atrial fibrillation, and smoking (p =
0.033; Table 2). The DBV in the stroke mimic group was
240.8 ± 38.1 mP. Laboratory findings affecting blood viscos-
ity were not different among the stroke subtypes, except for
elevated D-dimer level in CE (Table 1). The baseline SBV,
hematocrit, blood fibrinogen level, and BUN/Cr ratio were
not different among the stroke subtypes (Fig. 3b, c, d and e).
Blood viscosity and chronic radiological manifestations of
cerebral small vessel disease
The correlations between the major determinants of
blood viscosity such as the DBV, SBV, hematocrit, and
blood fibrinogen level and the chronic radiological mani-
festations of cerebral small vessel disease such as white
matter hyperintensities, lacunes, and microbleeds, were
investigated in all the patients regardless of the stroke
subtype. A statistically significant correlation was ob-
served between the DBV and the number of chronic
lacunes (r = 0.274, p = 0.030; Fig. 4a). The DBV showed
trends for positive correlation with the severity of PVH
(r = 0.135, p = 0.291; Fig. 4a) or the number of micro-
bleeds (r = 0.145, p = 0.256; Fig. 4a), although neither
reached statistical significance. The SBV, hematocrit, and
blood fibrinogen level were not significantly correlated with
any of the radiological manifestations (Fig. 4b, c, and d).
Temporal blood viscosity profiles
The follow-up blood viscosity was measured in 41 out of
the 63 patients (65.1%). The patients who were followed
up and those who were not followed up were not
a b c d
Fig. 2 The correlation of diastolic blood viscosity with hematocrit a and blood fibrinogen level b. The correlation of systolic blood viscosity with
hematocrit c and blood fibrinogen level d. *, p < 0.05; DBV, diastolic blood viscosity; SBV, systolic blood viscosity; Hct, hematocrit
a b c d e
Fig. 3 Blood viscosity and stroke subtypes. The diastolic blood viscosity was highest in patients with SAO stroke a. The systolic blood viscosity,
hematocrit, blood fibrinogen level, and BUN/Cr ratio were not different among the stroke subtypes b, c, d, and e. *p < 0.05 on ANOVA; **p < 0.05
on the post-hoc test; ns, not significant; SAO, small artery occlusion; LAA, large artery atherosclerosis; CE, cardioembolism; Cryp, cryptogenic stroke;
MM, stroke mimic; DBV, diastolic blood viscosity; SBV, systolic blood viscosity; Hct, hematocrit; BUN, blood urea nitrogen
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Table 2 Crude and adjusted odds ratios for the association with small artery occlusion stroke
Univariate analysis Multivariate analysis
Crude OR (95% CI) P value Adjusted OR (95% CI)** P value
Diastolic blood viscosity (per 1mP) 1.01 (1.00–1.02) 0.023* 1.01 (1.00–1.02) 0.033*
Systolic blood viscosity (per 1mP) 1.05 (0.99–1.12) 0.099 1.05 (0.99–1.10) 0.111
Hemoglobin (per 1 g/dL) 1.42 (1.04–1.94) 0.026* 1.27 (0.87–1.85) 0.223
Hematocrit (per 1%) 1.14 (1.01–1.28) 0.032* 1.09 (0.94–1.25) 0.252
Fibrinogen (per 1 mg/dL) 1.00 (0.99–1.01) 0.560 1.00 (0.99–1.01) 0.604
BUN/Cr ratio (per 1) 0.90 (0.80–1.01) 0.069 0.90 (0.79–1.02) 0.104
Abbreviations: OR odds ratio, CI confidence interval, BUN/Cr blood urea nitrogen-to-creatinine





Fig. 4 Correlation between laboratory findings, including diastolic blood viscosity a, systolic blood viscosity b, hematocrit c, and blood fibrinogen
level d, and chronic radiological manifestations of cerebral small vessel disease. *, p <0.05; DBV, diastolic blood viscosity; SBV, systolic blood
viscosity; Hct, hematocrit; PVH, periventricular hyperintensity; DWMH, deep white matter hyperintensity
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significantly different in their demographic character-
istics (Table 3). To investigate the role of blood vis-
cosity in SAO stroke, the patients were dichotomized
into the SAO and non-SAO groups. The baseline
DBV was significantly higher in the SAO group than
in the non-SAO group (274.7 ± 70.9 mP and 229.8 ±
70.0 mP, respectively; p = 0.016; Fig. 5a). The differ-
ence between the DBVs of the two groups was seen
to decrease at the 1-week follow-up (SAO, 232.7 ±
54.9 mP; non-SAO, 216.2 ± 48.0 mP; p = 0.394) and
increase again at the 5-week follow-up (SAO, 273.2 ±
48.9 mP; non-SAO, 218.6 ± 65.4 mP; p = 0.009; Fig. 5a).
In the SAO group, the DBV was elevated again and
returned to the baseline level at the stroke onset. On
the other hand, the DBV in the non-SAO group was
seen to remain within the same range at the 1-week
follow-up. The SBV at the 5-week follow-up was also
significantly higher in the SAO group than in the
non-SAO group (42.0 ± 4.3 mP and 36.1 ± 6.9 mP, respect-
ively; p = 0.005; Fig. 5b).
Discussion
Role of blood viscosity in SAO stroke
The whole blood viscosity at a low shear rate, equivalent
to the DBV in our study, is dependent on the aggrega-
tion of red blood cells in the lumen of small vessels [12,
13]. Both hematocrit and fibrinogen play key roles in the
aggregation of red blood cells [12, 13]. In our study, the
DBV was correlated with hematocrit, while the SBV was
correlated with the blood fibrinogen level. These find-
ings appear consistent with the hypothesis that at a low
shear rate, the red blood cells form a rouleaux and the
blood viscosity is predominantly determined by a func-
tion of the concentration and aggregation properties of
the red blood cells [24]. At a high shear rate, equivalent
to the SBV in our study, the red blood cells move as free
particles and the blood viscosity is determined not only
by the concentration of red blood cells, but also by the
plasma viscosity and deformability of red blood cells
[24]. Taken together, whole blood viscosity at a low or
high shear rate may be affected by the aggregation and
deformability of red blood cells or plasma viscosity, re-
spectively. In our study, we did not measure these indi-
vidual parameters that contribute to whole blood
viscosity. Thus, their effects on whole blood viscosity at
different shear rates require further investigation.
Considering that the DBV is more important than the
SBV for tissue perfusion at the level of small vessels, the
DBV may be more responsible than SBV for causing
cerebral small vessel disease. When the blood passes
through small vessels, an elevated DBV can aggravate
the flow disturbance and trigger endothelial remodeling
and luminal occlusion, which can lead to acute lacu-
nar infarction. In the general population, elevated
blood viscosity at a low shear rate or plasma viscosity
was correlated with silent cerebral infarction [11, 25].
In the population with stroke or at a high risk for
stroke, the blood viscosity at a low shear rate and the
plasma viscosity were both elevated [1]. Another
study of patients with stroke showed that the blood
viscosity was elevated over the entire range of shear
rates, especially at low shear rates [6]. A more spe-
cific study that included patients with cerebral small
vessel disease reported that the blood viscosity,
plasma viscosity, and blood fibrinogen level were all
elevated in patients with acute lacunar infarction [7].
More studies in relation to stroke subtypes in patients
with acute ischemic stroke showed that the blood or
plasma viscosity was higher in patients with SAO
than in patients with LAA or CE stroke [2–4]. Con-
sistent with previous reports suggesting hyperviscosity
in SAO stroke, the DBV was higher in patients with
SAO than in those with other stroke subtypes in our
study. Taken together, elevated DBV at the onset of
stroke can impair microvascular tissue perfusion and
Table 3 Comparison of demographics for patients followed-up
and not-followed-up
Followed-up
patients (n = 41)
Not-followed-up
patients (n = 22)
P value
Clinical findings
Age, years (mean ± sd) 65.1 ± 13.6 67.5 ± 13.7 0.496
Male, n (%) 25 (61.0) 16 (72.7) 0.415
Hypertension, n (%) 29 (70.7) 11 (50.0) 0.169
Diabetes, n (%) 12 (29.3) 4 (18.2) 0.382
Hyperlipidemia, n (%) 6 (14.6) 4 (18.2) 0.729
Atrial fibrillation, n (%) 6 (14.6) 3 (13.6) 1.000





258.9 ± 72.5 226.6 ± 71.3 0.623
Systolic blood viscosity,
mP
41.4 ± 9.5 41.3 ± 18.1 0.284
Hemoglobin, g/dL 14.2 ± 2.0 14.4 ± 1.7 0.598
Hematocrit, % 41.5 ± 5.5 41.9 ± 4.3 0.333
White blood cells, 103/μL 7.9 ± 3.1 7.5 ± 2.2 0.133
Platelets, 103/μL 228 ± 48 237 ± 73 0.104
Total protein, gm/dL 7.1 ± 0.4 6.9 ± 0.4 0.943
Fibrinogen, mg/dL 332 ± 71 325 ± 87 0.591
D-dimer, μg/dL 0.78 ± 1.25 0.63 ± 0.38 0.105
BUN/Cr ratio 21.0 ± 7.2 20.4 ± 5.0 0.500
Total cholesterol, mg/dL 167 ± 39 178 ± 36 0.943
Low-density lipoprotein,
mg/dL
102 ± 34 109 ± 30 0.760
Triglycerides, mg/dL 117 ± 81 92 ± 40 0.091
Abbreviations: sd standard deviation, BUN/Cr blood urea nitrogen-to-creatinine
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may be associated with the pathomechanisms involved
in SAO stroke.
Association between blood viscosity and chronic
radiological manifestations of cerebral small vessel
disease
The elevated blood viscosity at stroke onset may indicate
not only that acute hyperviscosity triggers stroke, but
also that underlying chronic hyperviscosity is present
prior to stroke. White matter hyperintensities, lacunes,
and microbleeds are various chronic radiological mani-
festations of cerebral small vessel disease [17–20].
Therefore, we hypothesized that if the blood viscosity at
stroke onset is also associated with white matter hyper-
intensities, lacunes, or microbleeds in patients with
acute ischemic stroke, the elevated blood viscosity at
stroke onset might have been present prior to stroke
onset.
The pathomechanisms of lacunes and white matter
hyperintensities are intimately related, and acute small
subcortical infarctions can progress to chronic lacunes
or white matter hyperintensities [19]. Ischemia and
chronic leakage of fluid and macromolecules are known
to be the main pathophysiologies attributed to the
development of white matter lesions [26]. More compli-
cated pathologies of white matter lesions, including
cerebral ischemia, ependymal loss, demyelination, and
microcytic infarction have also been reported [17, 26,
27]. The pathophysiology of microbleeds is a leakage of
red blood cells through the loosened blood-brain barrier
caused by bleeding-prone small vessel disease related to
hypertension or cerebral amyloid angiopathy [19].
Consistent with previous studies suggesting that blood
or plasma viscosity is associated with white matter
hyperintensities [11, 14, 25, 28, 29], the severity of PVH
in our study showed trends for positive correlation with
the DBV or blood fibrinogen level, although neither
reached statistical significance. Similar to previous stud-
ies that have indicated an association between the ele-
vated plasma viscosity and lacunar infarction [3, 11], we
observed a significant positive correlation between the
DBV and the number of chronic lacunes. Based on this
result, the elevated blood viscosity at stroke onset may
indicate hyperviscosity not only in the acute period but
also in the period prior to stroke onset. A prospective
observational study is needed to confirm this hypothesis.
Recurrent blood hyperviscosity in SAO stroke
To investigate the hyperviscosity in SAO stroke, stroke
subtypes were dichotomized into SAO and non-SAO
groups. The DBV at stroke onset was significantly higher
in the SAO group than in the non-SAO group. However,
this discrepancy decreased after 1 week, as the DBV de-
creased more dramatically in the SAO group than in the
non-SAO group. Dehydration leading to the elevation of
blood viscosity is considered to be one of the major fac-
tors responsible for triggering acute ischemic stroke [3,
4, 30]. Although the DBV was higher in SAO stroke than
in other stroke subtypes in our study, the BUN/Cr ratio,
which generally reflects the hydration status [31], was
not elevated in SAO stroke compared to that in other
stroke subtypes. The elevation of DBV in SAO stroke
may be caused not only by dehydration, but also by
other factors determining blood viscosity. The decrease
in the DBV at the 1-week follow-up may be mainly due
to the hydration therapy given after admission. In the
SAO group, the DBV measured at the 5-week follow-up,
when the hydration therapy was terminated, showed a
a b
Fig. 5 Temporal profiles of blood viscosity in SAO and non-SAO stroke. The baseline diastolic blood viscosity was higher in the SAO group than
that in the non-SAO group a. The difference between the two groups was seen to decrease at the 1-week follow-up, and increase at the 5-week
follow-up a. The systolic blood viscosity in the SAO group was higher than that in the non-SAO group at the 5-weeks follow-up b. *p < 0.05; DBV,
diastolic blood viscosity; SBV, systolic blood viscosity; SAO, small artery occlusion
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recurrent elevation even under the medication for second-
ary stroke prevention. The issue of chronic hyperviscosity
after stroke has been controversial [2, 4, 5, 7, 10]. Rheo-
logical abnormalities were observed in patients even when
they were under medication for secondary stroke preven-
tion in a cross-sectional study that included patients in
the chronic phase of stroke more than 3 months after the
onset [5, 10]. On the contrary, acute rheological abnor-
malities at stroke onset normalized over 2 months in
another study, regardless of the stroke subtype [2]. This
discrepancy may have resulted from the different methods
used to measure hyperviscosity or the different study pop-
ulations. A recent serial follow-up study of blood viscosity
measured at 100 s−1 for 2 weeks during the admission
period showed that the blood viscosity was highest at the
date of admission and decreased over the following
2 weeks [4]. While a serial follow-up for 2 weeks was
performed during the admission period [4], the follow-up
at 5 weeks in our study was performed at the outpatient
clinic when the hydration therapy had already been
terminated. Therefore, the results of our study may
reflect the chronic status of blood viscosity after
stroke, and are likely unrelated to the hydration ther-
apy administered during admission. The recurrent
elevation of the DBV in SAO stroke suggests that
chronic hyperviscosity may be a persistent underlying
pathomechanim of SAO stroke.
Limitations of our study
Our study has several limitations. First, the number of
patients included in our study is too small and the statis-
tical power to support our conclusion is relatively weak.
Second, a cross-sectional study design was used to inves-
tigate the role of blood viscosity in acute stroke onset or
chronic radiological manifestations of cerebral small
vessel disease. However, our results provide the rationale
for future prospective observational studies that might
confirm the cause-effect relationship. Third, follow-up of
the blood viscosity was not performed in all the patients
for various reasons. The number of patients lost to
follow-up was relatively high (n = 22, 34.9%). Although
there were no statistically significant differences in the
baseline clinical and laboratory profiles of the patients
who were followed-up and those who were not, baseline
DBV showed some non-significant differences (followed-
up, 258.9 ± 72.5 mP; not-followed-up, 226.6 ± 71.3 mP;
p = 0.623). This might have led to some selection bias.
Fourth, the blood viscosity can be easily influenced by
hydration therapy using fluids or drinking water. In order
to minimize the transient diluting effect by hydration,
samples for the baseline and follow-up measurements
were obtained before the hydration therapy and in a
fasting state, respectively.
Conclusions
Despite the above limitations, based on the results show-
ing positive correlations between DBV and SAO stroke
at acute stroke onset and chronic lacunar manifestation
of the small vessel disease, our study suggests that ele-
vated DBV may play a role in the development of acute
and chronic manifestations of cerebral small vessel
disease. The recurring elevation of the DBV in SAO
stroke, even when the patients were receiving medica-
tions for secondary stroke prevention, indicates that
sufficient hydration and additional therapeutic inter-
ventions targeting blood viscosity may be needed in
patients with SAO stroke.
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